EC Pharmacology and Toxicology

Objective: To investigate the prevalence of alcoholism, the levels of alcohol consumption, some comorbid diseases, and the gender difference in life expectancy (LE) in 160 countries 2004.

Materials and Methods: Study design: Statistical analysis of observations.

Using the Mann-Whitney U test, risk factors for the burden of alcoholism, levels of alcohol consumption, and the gender difference LE of women and men in 160 countries were studied.

Findings: The study found that the burden of alcoholism was 23 times higher in group 8 compared to group 1 in 160 countries in 2004. The main risk factor for alcoholism in men is not the total consumption of alcoholic beverages.

A statistically significant risk factor for alcoholism is the level of strong alcohol consumption. The gender difference in LE between women and men is statistically significantly higher in countries with a high burden of alcoholism. The popular belief about the same life expectancy of teetotalers and alcoholics cannot be considered true without taking into account the gender difference LE.

Conclusion: A risk factor for alcoholism is the level of strong alcohol consumption to a greater extent than the total consumption of wine, beer and strong alcohol. Gender difference LE depends not only on alcoholism. Risk factors for alcoholism and the gender difference in LE require further study.

Keywords: Wine; Beer; Strong Alcohol; Doses; The Burden of Alcoholism; Liver Cancer; Liver Cirrhosis; LE; Gender Difference

1. Minzer S., et al. “The Effect of Alcohol on Cardiovascular Risk Factors: Is There New Information?” Nutrients 4 (2020): 912.
2. Rocco A., et al. “Alcoholic disease: liver and beyond”. World Journal of Gastroenterology 40 (2014): 14652-14659.
3. Boden JM and Fergusson DM. “Alcohol and depression”. Addiction5 (2011): 906-914.
4. Schuckit MA. “Alcohol-use disorders”. Lancet 9662 (2009): 492-501.
5. Wood E., et al. “Will This Hospitalized Patient Develop Severe Alcohol Withdrawal Syndrome?: The Rational Clinical Examination Systematic Review”. Journal of the American Medical Association 8 (2018): 825-833.
6. Eloma AS., et al. “Evaluation of the appropriate use of a CIWA-Ar alcohol withdrawal protocol in the general hospital setting”. American Journal of Drug and Alcohol Abuse4 (2018): 418-425.
7. Erol A and Karpyak VM. “Sex and gender-related differences in alcohol use and its consequences: Contemporary knowledge and future research considerations”. Drug and Alcohol Dependence 156 (2015): 1-13.
8. Campollo O. “Alcohol and the Liver: The Return of the Prodigal Son”. Annals of Hepatology 1 (2019): 6-10.
9. Bailey KL., et al. “Alcohol use disorder: A pre-existing condition for COVID-19?” Alcohol 90 (2021): 11-17.
10. Engler PA., et al. “Alcohol use of diabetes patients: the need for assessment and intervention”. Acta Diabetologica 2 (2013): 93-99.
11. Gowin JL., et al. “Vulnerability for Alcohol Use Disorder and Rate of Alcohol Consumption”. American Journal of Psychiatry 11 (2017): 1094-1101.
12. Aghdassi AA., et al. “Genetic susceptibility factors for alcohol-induced chronic pancreatitis”. Pancreatology4 (2015): S23-S31.
13. González-Reimers E., et al. “Alcoholism: a systemic proinflammatory condition”. World Journal of Gastroenterology 40 (2014): 14660-14671.
14. Farris SP and Miles MF. “Ethanol modulation of gene networks: implications for alcoholism”. Neurobiology of Disease 1 (2012): 115-121.
15. Schuckit MA. “Studies of populations at high risk for alcoholism”. Psychiatric Developments1 (1985): 31-63.
16. da Costa MZ., et al. “Genetic risk for alcoholic chronic pancreatitis”. International Journal of Environmental Research and Public Health 7 (2011): 2747-2757.
17. Schuckit MA. “Genetics and the risk for alcoholism”. Journal of the American Medical Association 18 (1985): 2614-2617.
18. de la Monte SM and Kril JJ. “Human alcohol-related neuropathology”. Acta Neuropathologica 1 (2014): 71-90.
19. Le Daré B., et al. “Ethanol and its metabolites: update on toxicity, benefits, and focus on immunomodulatory effects”. Drug Metabolism Reviews 4 (2019): 545-561.
20. World Health Organization. The global burden of disease: 2004 update. Geneva, WHO (2008).
21. United Nations Department of Economic and Social Affairs/Population Division. 2009. World Population Prospects (2008).
22. World Health Organization. Average daily ambient ultraviolet radiation (UVR) level. World Health Data Platform/GHO/Indicator Metadata Registry List Average daily ambient ultraviolet radiation (UVR) level (2004).
23. World Population Prospects United Nations. 2005-2010.
24. Bhaven N Sampat. “Academic Patents and Access to Medicines in Developing Countries”. American Journal of Public Health 1 (2009): 9-17.
25. Gross National Happiness Commission. Royal Government of Bhutan.
26. Global Health Observatory (GHO) data Indicator and Measurement Registry version 1.7.0 BMI ≥ 25 total cholesterol ≥ 5.0 blood glucose ≥ 7.0 insufficiently active. 2008 // WHO (World Health Organization) Percentage of defined population Program Country (2008).
27. Food and Agriculture Organization of the United Nations. Food Balance Sheets 2003-05.
28. Treskov VG., et al. “[Clinical pharmacokinetics of mebikar. Computation of individual dosage regimens]”. Farmakologiia i Toksikologiia 1 (1985): 46-48.
29. Treskov VG., et al. “[Plasma levels of biogenic amines in patients with various forms of the alcohol abstinence syndrome]”. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 2 (1989): 109-111.
30. Radkevich LA and Radkevich DA. “Comparative Analysis of Economic, Geographic, Social and Nutritional Risk Factors 4 Types of Non-Communicable Chronic Diseases (Melanoma, Multiple Sclerosis, Diabetes Mellitus and Hypertensive Heart Disease) in the Mediterranean and Caribbean Countries (Population Study)”. Journal of Obesity and Chronic Diseases 2 (2020): 51-58.
31. Ludmila Radkevich and Dariya Radkevich. “Can Alcohol and Obesity be Considered Risk Factors for Diabetes Mellitus? (environmental study)”. Current Research in Diabetes and Obesity Journal 1 (2021): 555905.
32. Lyudmila Alexandrovna Radkevich and Dariya Andreyevna Radkevich. “Analysis of the Burden of Cardiovascular Morbidity in Countries with High and Low Levels of Daily Food Consumption”. Online Journal of Cardiology Research and Reports (2021).
33. Lyudmila Alexandrovna Radkevich and Dariya Andreyevna Radkevich. “Dietary Patterns and Economic and Geographic Risk Factors for the Burden of Diabetes Mellitus (Observational Study)”. EC Diabetes and Metabolic Research4 (2021): 82-96.
34. Radkevich LA., et al. “Mortality from suicide and alcoholism, depending on the level of alcohol consumption”. Research and Practical Medicine Journal1 (2017): 33-39.
35. Angela M Wood., et al. “Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies”. The Lancet10129 (2018): 1513-1523.
36. Kalinowski A and Humphreys K. “State standard definitions and recommendations for use low-risk alcohol in 37 countries”. Addiction7 (2016): 1293-1298.
37. Thun MJ., et al. “Alcohol consumption and mortality among middle-aged and elderly U.S. adults”. New England Journal of Medicine 24 (1997): 1705-1714.
38. Mukamal K., et al. “Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men”. New England Journal of Medicine 2 (2003): 109-118.
39. Stampfer MJ., et al. “A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women”. New England Journal of Medicine 5 (1988): 267-273.
40. Boffetta P and Garfinkel L. “Alcohol use and mortality among men included in a prospective study by the American Cancer Society”. Epidemiology5 (1990): 342-348.
41. Verbrugge LM and Wingard DL. “Sex differentials in health and mortality”. Women and Health2 (1987): 103-145.
42. Waldron I. “What do we know about causes of sex differences in mortality? A review of the literature”. Population Bulletin of the United Nations 18 (1985): 59-76.
43. Verbrugge LM and Wingard DL. “Sex differentials in health and mortality”. Women and Health2 (1987): 103-145.
44. Trias-Llimós S and Janssen F. “Alcohol and gender gaps in life expectancy in eight Central and Eastern European countries”. The European Journal of Public Health4 (2018): 687-692.
45. Koob GF. “Neurocircuitry of alcohol addiction: synthesis from animal models”. Handbook of Clinical Neurology 125 (2014): 33-54.
46. Comings DE and Blum K. “Reward deficiency syndrome: genetic aspects of behavioral disorders”. Progress in Brain Research 126 (2000): 325-341.
47. Lucey MR. “Alcohol-Associated Cirrhosis”. Clinical Liver Disease 1 (2019): 115-126.
48. Ludmila Radkevich and Dariya Radkevich. “Comparative Analysis of Risk Factors for Liver Cirrhosis in the World”. Academic Journal of Gastroenterology and Hepatology 2 (2021): AJGH.MS.ID.000557.
49. Ludmila Alexandrovna Radkevich and Dariya Andreyevna Radkevich. “2004 Study of Risk Factors for an Increasing Gradient in the Burden of Liver Cirrhosis in 158 Countries in Men and Women”. Acta Scientific Gastrointestinal Disorders3 (2020): 19-40.
50. Baecker A., et al. “The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention. Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors”. European Journal of Cancer Prevention 3 (2018): 205-212.
51. Nyberg AH., et al. “Increased cancer rates in patients with chronic hepatitis C”. Liver International 3 (2020): 685-693.
52. Global Burden of Disease Liver Cancer Collaboration., et al. “The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results from the Global Burden of Disease Study 2015”. JAMA Oncology12 (2017): 1683-1691.
53. Fattovich G., et al. “Hepatocellular carcinoma in cirrhosis: incidence and risk factors”. Gastroenterology 5 (2004): S35-S50.